Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.51B | 2.53B | 2.53B | 2.54B | 2.55B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.51B | 2.53B | 2.53B | 2.54B | 2.55B |
| Cost of Revenue | 772.29M | 771.59M | 763.47M | 756.04M | 753.56M |
| Gross Profit | 1.74B | 1.76B | 1.76B | 1.79B | 1.80B |
| SG&A Expenses | 1.26B | 1.28B | 1.30B | 1.32B | 1.33B |
| Depreciation & Amortization | 368.50M | 364.08M | 358.76M | 359.96M | 363.53M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.67B | 2.69B | 2.71B | 2.73B | 2.74B |
| Operating Income | -157.19M | -163.40M | -178.59M | -183.49M | -186.65M |
| Income Before Tax | -185.11M | -235.53M | -250.08M | -232.36M | -1.03B |
| Income Tax Expenses | -13.96M | -35.21M | -26.50M | -25.00M | -13.35M |
| Earnings from Continuing Operations | -171.15 | -200.32 | -223.59 | -207.36 | -1.01K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -171.15M | -200.32M | -223.59M | -207.36M | -1.01B |
| EBIT | -157.19M | -163.40M | -178.59M | -183.49M | -186.65M |
| EBITDA | 47.51M | 33.06M | 16.17M | 18.88M | 32.82M |
| EPS Basic | -0.96 | -1.14 | -1.28 | -1.19 | -5.93 |
| Normalized Basic EPS | -0.49 | -0.48 | -0.55 | -0.53 | -0.57 |
| EPS Diluted | -0.96 | -1.14 | -1.28 | -1.19 | -5.93 |
| Normalized Diluted EPS | -0.49 | -0.48 | -0.55 | -0.53 | -0.57 |
| Average Basic Shares Outstanding | 709.81M | 704.84M | 699.77M | 694.33M | 688.65M |
| Average Diluted Shares Outstanding | 709.81M | 704.84M | 699.77M | 694.33M | 688.65M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |